This inventor holds 2 USPTO granted patents. Top assignees: Ajinomoto Co., Ltd., Other. Active years: 1984-1985.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Sendai, JP (1984)
- Minami, Yagiyama, Sendai-shi, Miyagi-ken, JP (1985)
Company Filing History:

Years Active: 1984-1985
Title: Isao Yamane: Innovator in Cell Culture Technology
Introduction
Isao Yamane is a notable inventor based in Sendai, Japan. He has made significant contributions to the field of cell culture technology, particularly in the development of innovative culture media and cell lines. With a total of 2 patents, his work has implications for both research and therapeutic applications.
Latest Patents
Yamane's latest patents include a culture medium that utilizes cyclodextrin, which has been found to exhibit minimal cytotoxicity on cell growth. This culture medium incorporates lipophilic substances, such as unsaturated fatty acids and lipophilic vitamins, to promote cell growth and enhance the productivity of valuable products. Another significant patent involves a process for preparing a continuous and spontaneous human-interferon-producing lymphoblastoid cell line. This process transforms human lymphocytes from infants or aborted fetuses using Epstein Barr Virus, resulting in a cell line capable of producing over 1000 units of interferon per milliliter.
Career Highlights
Throughout his career, Isao Yamane has worked with prominent companies, including Ajinomoto Co., Ltd. His expertise in cell culture and biotechnology has positioned him as a key figure in his field.
Collaborations
Yamane has collaborated with notable individuals such as Yoshiki Minamoto and Mikio Kan. These partnerships have likely contributed to the advancement of his research and innovations.
Conclusion
Isao Yamane's contributions to cell culture technology through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the fields of biotechnology and medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile